CGEM Cullinan Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology

Get AI intraday signals

CGEM

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CGEM
(Try 14 days for $1 only)

View a ticker or compare two or three

Compare

CGEM

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CGEM
(Try 14 days for $1 only)

Ad is loading...

A.I. Advisor

published Earnings

CGEM is expected to report earnings to rise 5.67% to -79 cents per share on November 11

Cullinan Therapeutics CGEM Stock Earnings Reports

Q3'24

Est.

$-0.79

Q2'24

Missed

by $0.02

Q1'24

Beat

by $0.13

Q4'23

Beat

by $0.42

Q3'23

Beat

by $0.01

The last earnings report on August 08 showed earnings per share of -75 cents, missing the estimate of -72 cents. With 394.07K shares outstanding, the current market capitalization sits at 996.62M.

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

One Main Street

Phone

+1 617 410-4650

Employees

Web

https://www.cullinanoncology.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
GME	23.14	-0.28	-1.20%
GameStop Corp
TSLA	210.60	-3.51	-1.64%
Tesla
SPY	552.08	-11.60	-2.06%
SPDR® S&P 500® ETF Trust
AAPL	222.77	-6.23	-2.72%
Apple
BTC.X	57431.023000	-1681.457000	-2.84%
Bitcoin cryptocurrency

CGEM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with FATE. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then FATE could also see price increases.

Ticker / NAME	Correlation To CGEM	1D Price Change %
CGEM	100%	-5.56%
FATE - CGEM	38% Loosely correlated	-5.99%
ATXI - CGEM	37% Loosely correlated	+9.84%
TNYA - CGEM	37% Loosely correlated	-5.60%
DNA - CGEM	36% Loosely correlated	-8.82%
ZVSA - CGEM	35% Loosely correlated	-2.90%
More